Infectious Bursal Disease Vaccine Market – Global Market Growth and Industry Trends

The Infectious Bursal Disease Vaccine Market is gaining importance as poultry producers increasingly focus on disease prevention, flock health, and productivity. Infectious bursal disease (IBD), commonly associated with Gumboro disease, is a highly contagious viral infection affecting poultry, particularly young chickens. The disease can weaken immune function and create significant economic losses for poultry producers. Increasing poultry production and the need for effective disease-control programs are therefore supporting demand for IBD vaccines. Independent market research indicates that the global market is expected to grow at approximately 5.2% CAGR from 2025 to 2031.

Vaccination remains an important component of poultry health management because prevention can reduce disease-related losses and support flock performance. Live vaccines are expected to experience strong demand because they can provide rapid and durable immunity, while inactivated vaccines remain important for specific vaccination programs.

Technological development is also influencing the market. Manufacturers are working on improved vaccine formulations, delivery methods, and recombinant approaches to enhance effectiveness and safety. Expanding poultry farming in Asia-Pacific and other emerging regions is creating additional opportunities.

Overall, rising poultry consumption, increasing awareness of animal health, disease outbreaks, and advancements in veterinary vaccine technology are expected to support continued growth of the infectious bursal disease vaccine industry.